FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to genetic engineering and may be used in biotechnology to produce proteins of practical interest, which are a product of silent genes or low expression genes. What is presented is a method for producing a recombinant protein of human renalase 2 involving a) preparing a complete cDNA sequence, and b) expressing the prepared sequence in E.coli, wherein the stage (a) is performed by PCR amplification of each exon using specific primer pairs and a genomic DNA as a matrix, followed by twinning requiring no pre-treatment and involving the same method for adjacent exons at first, and then being the product of their amplicon combining. In this case, the primers twice exceeding exons in number are selected so that the forward primer contain a terminal sequence of the preceding exon and an initial sequence of the exon to be copied; the downstream primers contain only a sequence complementary to the end of the amplified exons, while the forward and downstream primers flanking the complete coding sequence contain restriction sites necessary for integration into a plasmid vector.
EFFECT: preparing the proteins of practical interest which are the products of silent genes or low expression genes.
2 tbl, 7 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR AMPLIFICATION OF NUCLEIC ACIDS OF HEAVY AND LIGHT CHAINS OF HUMAN IMMUNOGLOBULINS FOR THE CREATION OF RECOMBINANT ANTIBODIES, PRIMER COMPOSITIONS (VARIANTS) | 2020 |
|
RU2775914C2 |
METHOD FOR CONSTRUCTING MAMMALIAN MINIGENES AND RECOMBINANT PLASMID PGC1HDR ENCODING THE HUMAN C1 ESTERASE INHIBITOR MINIGENE INTENDED FOR PRODUCING MICE HUMANIZED BY THE SERPING1 GENE | 2022 |
|
RU2805177C1 |
METHOD OF OBTAINING SYNTHETIC CG-RICH GENETIC SEQUENCE AND ITS USE IN PLANTS | 2016 |
|
RU2630650C1 |
METHOD OF IDENTIFYING POLYMORPHISM R287Q IN 8 EXON GENE CYTOSOLIC EPOXIDE HYDROLASE IN HUMAN BEINGS | 2006 |
|
RU2346053C2 |
GENETIC MAKE-UPS FOR ANTI-HIV THERAPY | 2010 |
|
RU2426788C1 |
IMPROVING GENETIC CONSTRUCTS FOR PROVIDING HIGH EFFICACY OF ANTI-HIV THERAPY | 2013 |
|
RU2533817C1 |
DETERMINATION OF GENE ZG16 mRNK LEVEL REDUCTION AS METHOD OF LARGE INTESTING CANCER DIAGNOSTICS AND SET OF ITS REALISATION | 2009 |
|
RU2395234C1 |
METHOD FOR INDIRECT DETERMINATION OF THE COMPLETENESS OF FMD VIRUS ANTIGEN INACTIVATION IN VACCINE RAW MATERIALS USING REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION IN REAL TIME WITH AMPLIFICATION OF LARGE-SIZED FRAGMENT | 2021 |
|
RU2753969C1 |
METHOD OF DIAGNOSING CLEAR CELL RENAL CELL CARCINOMA AND SET FOR ITS REALISATION | 2012 |
|
RU2545998C2 |
STRAIN E coli BL21(DE3)/pET-hHSP70 - PRODUCENT OF PROTEIN OF HEAT SHOCK IN HUMANS HSP70 | 2006 |
|
RU2333956C1 |
Authors
Dates
2013-05-20—Published
2011-05-27—Filed